- Home
- SKYE vs IONR Comparison
SKYE vs IONR Comparison
Compare SKYE & IONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- IONR
- Stock Information
- Founded
- SKYE 2012
- IONR 2001
- Country
- SKYE United States
- IONR Australia
- Employees
- SKYE N/A
- IONR N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- IONR
- Sector
- SKYE Health Care
- IONR
- Exchange
- SKYE Nasdaq
- IONR Nasdaq
- Market Cap
- SKYE 94.0M
- IONR 319.2M
- IPO Year
- SKYE N/A
- IONR N/A
- Fundamental
- Price
- SKYE $2.73
- IONR $4.11
- Analyst Decision
- SKYE Buy
- IONR
- Analyst Count
- SKYE 6
- IONR 0
- Target Price
- SKYE $18.67
- IONR N/A
- AVG Volume (30 Days)
- SKYE 167.7K
- IONR 25.0K
- Earning Date
- SKYE 02-09-2025
- IONR 01-01-0001
- Dividend Yield
- SKYE N/A
- IONR N/A
- EPS Growth
- SKYE N/A
- IONR N/A
- EPS
- SKYE N/A
- IONR N/A
- Revenue
- SKYE N/A
- IONR N/A
- Revenue This Year
- SKYE N/A
- IONR N/A
- Revenue Next Year
- SKYE N/A
- IONR N/A
- P/E Ratio
- SKYE N/A
- IONR N/A
- Revenue Growth
- SKYE N/A
- IONR N/A
- 52 Week Low
- SKYE $2.25
- IONR $2.90
- 52 Week High
- SKYE $19.41
- IONR $9.35
- Technical
- Relative Strength Index (RSI)
- SKYE 37.40
- IONR 42.24
- Support Level
- SKYE $2.31
- IONR $3.71
- Resistance Level
- SKYE $3.04
- IONR $4.58
- Average True Range (ATR)
- SKYE 0.30
- IONR 0.34
- MACD
- SKYE 0.07
- IONR 0.07
- Stochastic Oscillator
- SKYE 44.68
- IONR 51.04
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About IONR ioneer Ltd
Ioneer Ltd is a mineral exploration company. The company's focus is on the Rhyolite Ridge Lithium-Boron Project located in Nevada, USA. Geographically, the group has a business presence in Australia and North America. The company's focus is to develop a U.S.-based source of lithium and boron that can be extracted in an environmentally and socially responsible manner, providing two materials that are essential to achieve a sustainable future for the planet.